Early PCI now favored in stable CAD

May 25, 2018|Cardiology News

REPORTING FROM EUROPCR 2018

Asked what she would do differently if she could do ORBITA over again, Dr. Al-Lamee didn’t hesitate: “If I were to do it again, I absolutely agree that exercise time would not be the primary endpoint I would choose.”

SCAAR

Elmir Omerovic, MD, PhD, presented an update from the long-running observational prospective Swedish national registry. The analysis included 3,460 patients who underwent PCI for stable angina with FFR and/or iFR guidance and 21,221 others whose PCI was performed based solely on coronary angiography.

At 10 years of follow-up, total mortality was an adjusted 17% less in the FFR/iFR group. Moreover, their composite rate of restenosis/stent thrombosis was reduced by 31%, added Dr. Omerovic, professor of cardiology at the University of Gothenburg, Sweden.

At the beginning of the 10-year study period, FFR/iFR was utilized in 5%-6% of PCIs for stable CAD; today that rate has climbed to 40%, according to the cardiologist.